The postthrombotic syndrome (PTS) is chronic venous insufficiency secondary to a prior
deep vein thrombosis (DVT). It is the most common complication of venous …

Background: Post-thrombotic syndrome (PTS) is a common and debilitating sequela of lower
limb deep vein thrombosis (DVT). There is significant heterogeneity in reported PTS …

Venous thromboembolism, which includes deep venous thrombosis (DVT) and pulmonary
embolism, is the third most common vascular disease in the world and seriously threatens …

Introduction Postthrombotic syndrome (PTS) remains associated with significant clinical and
economic burden. This study aimed to investigate known and novel predictors of the …

In the phase 2b/3 DIVERSITY trial, 3 months treatment with dabigatran was noninferior to
standard of care (SOC) for acute venous thromboembolism (VTE) in children. In a single …

Background Venous thromboembolism (VTE) affects> 1.2 million Americans annually.
Although the clinical outcomes and economic burdens of VTE have been well described, the …

Background: Postthrombotic syndrome (PTS) has a major impact on the quality of life after
deep venous thrombosis (DVT). From clinical practice and related trials, anticoagulants …

The incidence of post-thrombotic syndrome (PTS) in patients with deep vein thrombosis
(DVT) treated with direct oral anticoagulants (DOACs) remains a matter of debate. Hence …

OBJECTIVE: Post-thrombotic syndrome (PTS) is a common chronic complication of deep
vein thrombosis. Elastic compression (ECS) is the common pillar for PTS prevention and …

Objective Up to 50% of patients recovering from pulmonary embolism (PE) experience
negative long-term outcomes. Patient-reported outcome measures (PROMs) are important in …